Adverse Drug Reaction Onsets in Uganda’s VigiBase®: Delayed International Visibility, Data Quality and Illustrative Signal Detection Analyses-Reference-Cited by-同舟云学术

Adverse Drug Reaction Onsets in Uganda’s VigiBase®: Delayed International Visibility, Data Quality and Illustrative Signal Detection Analyses

Published:2018-11-17 Issue:6 Volume:32 Page:413-427
ISSN:1178-2595
Container-title:Pharmaceutical Medicine
language:en
Short-container-title:Pharm Med

Author:

Kiguba Ronald^ORCID,Ndagije Helen B.,Nambasa Victoria,Bird Sheila M.

Funder

Alborada Trust

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/article/10.1007/s40290-018-0253-7/fulltext.html

Reference28 articles.

1. WHO Collaborating Centre for International Drug Monitoring. Members of the WHO Programme for International Drug Monitoring. 2018. https://www.who-umc.org/global-pharmacovigilance/members/who-programme-members/ . Accessed 22 Mar 2018.

2. National Pharmacovigilance Centre. What is current practice of Pharmacovigilance in Uganda? 2012. https://africapv2012.files.wordpress.com/2012/04/day-2_5_country-presentations-nras_h-ngadije-uganda-compatibility-mode.pdf . Accessed 22 Mar 2018.

3. Uganda Bureau of Statistics. National Population and Housing Census 2014—Main Report. 2016. http://www.ubos.org/2016/03/24/census-2014-final-results/ . Accessed 23 Mar 2018.

4. Dheda M. Perspectives on the emergence of pharmacovigilance in Public Health Programmes in South Africa. Pharm Med. 2016;30(4):213–9.

5. Olowofela A, Fourrier-Réglat A, Isah AO. Pharmacovigilance in Nigeria: an overview. Pharm Med. 2016;30(2):87–94.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Med Safety mobile app for reporting adverse events in Burkina Faso;Drugs & Therapy Perspectives;2024-07-27

2. Surveillance des effets indésirables lors des campagnes de la chimioprévention du paludisme saisonnier chez les enfants de 3-59 mois au Burkina Faso;Santé Publique;2023-12-22

3. Profile of adverse drug reaction reports in South Africa: An analysis of VigiBase® for the year 2017;South African Medical Journal;2023-06-05

4. Frequency, severity, and factors associated with clinically significant drug-drug interactions among patients with cancer attending Mbarara Regional Referral Hospital Cancer Unit, Uganda;BMC Cancer;2022-12-05

5. Prevalence and factors associated with adverse drug reactions among heart failure patients hospitalized at Mbarara Regional Referral Hospital, Uganda;BMC Cardiovascular Disorders;2022-11-11